Organic and inorganic growth potential from rising demand in the healthcare sector
€75.9mn
Equity investment
€75mn
Revenues 2018 (proforma)
750
Employees 2018

KEY FACTS AT A GLANCE

  • Complete range of radiology and nuclear medicine modalities, treatments and interventions
  • Kidney care with in-centre and dialysis@home
  • Group of practices provides further opportunities, driven by organic and expansionary growth

BLIKK HOLDING GMBH

Investment by
DBAG FUND VII

€75.9MN

DBAG'S INTEREST

€16.5MN

MANAGEMENT BUYOUT
Shareholders:
DBAG FUND VII

56.1%

EQUITY SHARE BELONGING TO DBAG

12.1%

other shareholders

31.8%

First invested

MAY 2019

REVENUES in €mn

 

75 

 

2018 (PROFORMA)

As of May 2019

The blikk Group with its practices is already one of the market leaders in Germany with regard to the number of radiological examinations and findings. We are investing in a dynamic, innovative group of companies with great growth potential and a clear strategic roadmap.

LUCAS HERBERT
MANAGING DIRECTOR

PROFILE

blikk Group merges radiology, nuclear medicine and kidney practices/dialysis, thus making a major contribution towards ensuring top-class medical care. Group practices act as innovative partners for patients, physicians and cooperating hospitals.

They currently employ more than 750 people at 20 sites in North Rhine-Westphalia, Hamburg and Braunschweig that provide the complete range of state-of-the-art diagnostic imaging. Their pioneering role in closely combining outpatient and inpatient care is rooted in many years of collaborative experience with hospitals, offering both inpatient and outpatient imaging and nuclear medicine diagnostics to patients.

Managed by operasan GmbH, the kidney care business provides renal patients with the complete range of modalities and treatments, including dialysis. The radiology and nephrology disciplines also combine imaging modalities with interventional oncology options to treat both benign and malignant kidney tumours, to name but one example of joint research and practice.

blikk Group leverages ground-breaking technologies and methods, and is continuously expanding its capacities and range of medical disciplines. In so doing, the Group is poised to tackle the challenges arising from demographic change, technological disruption and new diseases. Key competitive differentiators include the practices’ ability to provide top-class imaging and diagnostics as well as highly efficient processes and appointments at short notice.

POTENTIAL FOR DEVELOPMENT

The transaction is geared to support the long-term organic and expansionary growth of blikk Group in Germany.

The benefits derived from the group structure also constitute compelling arguments for other practices to join the Group. Physicians and patients alike profit from the sharing of knowledge between medical practitioners within a network of experts. In addition, practices are in a stronger position to jointly invest in medical specialists and other skilled staff, as well as in capital-intensive equipment and digital systems.

Core medical processes at the practices are streamlined by centralising and professionalising administrative tasks and responsibilities, thus increasing the quality and effectiveness of operations. The Group has already assumed a pioneering role in the digitalisation of processes and workflows in the radiology segment as a result of strategic partnerships entered into with equipment and software providers. It is also actively involved in developing AI-driven standards for day-to-day practice.

Taken together, all of the above makes the blikk Group practices attractive partners as part of both existing and envisaged cooperation agreements with hospitals.

Responsible team member

Lucas Herbert
Lucas Herbert

Managing Director

Lucas Herbert
Name:
Lucas Herbert
Telephone:
+49 69 95787-208
E-Mail:

Lucas Herbert

Managing Director

Lucas Herbert joined Deutsche Beteiligungs AG in 2007 and became a Managing Director in 2015.

He holds a Master of Science in Business Administration from the Rotterdam School of Management, Erasmus University, and also studied at the Maastricht University and the University of Newscastle, Australia.

Lucas Herbert has eleven years of experience in the private equity sector. During this time, he has gained extensive knowledge, particularly in the IT services/software, mechanical and plant engineering and healthcare sectors. Lucas Herbert has been involved in a large number of corporate investments and disposals. These include Romaco, Spheros, Gienanth and Silbitz. He also led the investment process in blikk and Cloudflight.

Current portfolio companies

Gienanth Group GmbH

Former portfolio companies

Lucas Herbert

Managing Director

+49 69 95787-208
lucas.herbert(at)dbag.de